ReviewMaterials today. Bio2026
Bioactive glass-based core-shell nanoparticles: Multifunctional platforms for controlled drug release and biomedical applications.
Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Silica based nanocarriers for combination immunotherapy targeting the tumor immune microenvironment.Drug delivery and translational research · 2026Review
- Organ-on-chip (OoC) and nano-biomaterials: next generation of precision oral and dental healthcare research.Journal of nanobiotechnology · 2026Review
- Interpulse-Interval-Controlled Nanoparticle Formation in Gas-Phase Burst-Mode Femtosecond Laser Ablation.Nanomaterials (Basel, Switzerland) · 2026Article
- The Role and Potential of Nanotechnology in Improving Solubility and Enhancing Bioavailability.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Core-shell engineered nanoparticles have emerged as multifunctional platforms for biomedical applications by enabling precise spatial control over their structure, controlled release, and interaction with biological tissues. Among the core materials, bioactive glasses offer unique advantages over conventional silica due to their intrinsic bioactivity and the release of therapeutic ions. This review provides a comprehensive analysis of core-shell nanostructures that use bioactive glass as the core, and shells composed of a wide range of inorganic and polymeric materials, engineered to control their release capabilities and biological performance. The composition and synthesis strategies of bioactive glass nanoparticles are discussed. The types of shell materials are also evaluated, highlighting their physicochemical roles in modulating drug diffusion, stability, degradation, and biological targeting. Inorganic, natural, and synthetic polymeric shells are discussed, focusing on how they can be used to tailor the properties of the nanoparticles. Key challenges related to in vivo performance assays, immunological responses, degradation behavior, and translational barriers, outlining future directions for clinical implementation, are also explored. By integrating the structural functionalities of bioactive glasses with advanced surface engineering, the core-shell structures discussed in this review represent a versatile, highly tunable and customizable strategy for next-generation biomedical therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.